Clinical Research in Core vs. Non-Core Countries

<< Prev 17 of 23 in Topic Next >>

Rate :

Posted in Community :

	Clinical Research in Core vs. Non-Core Countries Created by : Sreenivas Hebbare, Product Development Manager, Ranbaxy Labs \| 09 03 2008 01:37:37 +0000 Industry : PharmaceuticalsFunctional Area : R&D(Operations) Keywords : Clinical Research Countries Core Non-Core Activity: 348 views; last activity : 07 06 2010 20:18:09 +0000 In the past millennium clinical studies were mainly performed in countries that had a larger market size for that drug, But in recent years, prolonged drug development process along with a steady increase in expenses have promoted pharmaceutical and biotechnology companies to look for more cost-effective ways to conduct clinical trials. Which option is better?

Refer 7

Rate :

Core Countries

Non Core Countries

Support


Sort by : Most Recent Top Rated
Support "Core Countries" edit in rich text ... Submit Cancel Saving ... 0 0 Performing the research in the core countries help in getting the funds easily and yes the development process also dos not take much time. If it is non core countries or the developing nations then Lack of control in purchasing drugs in developing countries will cause easier access to different medications; this will result in an increased number of side effects and drug interactions. By Sreenivas Hebbare, Product Development Manager, Ranbaxy Labs \| 09 03 2008 01:37:37 +0000 Edit \| Delete Support \| Oppose	Support "Non Core Countries" edit in rich text ... Submit Cancel Saving ... 0 0 Economical status and limited access to health care are two important plus point for developing countries. Its is cheap here to conduct clinical research. Sponsors will be able to collect scientific sound data from diverse populations with genetic differences that may enhance their post approval marketing and developing countries will receive a portion from almost $200 billion market. By Sumit Bansal, Product Development Manager, Novartis \| 09 03 2008 01:38:26 +0000 Edit \| Delete Support \| Oppose
Argue for "Core Countries"	Argue for "Non Core Countries"
Prev1NextShowing 1 - 1 of 1

Making the right connections

VP Operations Finance, FMCG, Bangalore

Branding Strategy, Marketing, Media, Marketing Manager, FMCG, Bangalore

Viewers also viewed

	For Herbal composition do we have to perform clinical trials and send report to DCGI
	Hi All, One of my friends has herbal composition ready to be launched in Indian market? Is it...
	3 referals 2 answers, 692 views

	"Instant relief, no side effects" isin't it good, Choice is more with lots of opportunity!!!
	Arre, I need to catch my train at 6:42pm ambernath yaar. Or else will be too late. With so...
	1203 referals 12 arguments, 442 views

	IS INDIA MOVING TO A DEVELOPED COUNTRY?
	YES vs NO
	679 referals 38 arguments, 2333 views

more...

Full name*:
Email address*:
New password*:
	Sign Up or Log In
By clicking 'Sign Up' above you are agreeing to the Terms of Service and Privacy Policy of TooStep